Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.

@article{Hodis2003RandomizedCT,
  title={Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.},
  author={Howard N. Hodis and Wendy J. Mack and Rog{\'e}rio Souza Lobo},
  journal={Circulation},
  year={2003},
  volume={108 1},
  pages={e5; author reply e5}
}
Estrogen Replacement Therapy Reduces the Progression of Subclinical Atherosclerosis in Healthy Postmenopausal Women Without Preexisting Cardiovascular Disease To the Editor: Two articles have appeared in Circulation1,2 that have cited the Estrogen in the Prevention of Atherosclerosis Trial (EPAT)3 as supportive evidence that hormone replacement therapy (HRT) has no benefit on atherosclerosis in women with established cardiovascular disease (CVD). Citation of EPAT as supportive evidence for such… CONTINUE READING